Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia

Schizophrenia Research

Volumn 86, Issue 1-3, 2006, Pages 167-171

  Wolf, Teri L ^a   Kotun, Joan ^b   Meador Woodruff, James H ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cupric enzymes; Dopamine; Iron oxidase; Metalloenzymes; Trace metals; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER; FERRIC ION; TRANSFERRIN;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION ANALYSIS; ENZYMATIC ASSAY; ENZYME ACTIVITY; HOSPITAL PATIENT; HUMAN; IRON BLOOD LEVEL; MALE; OXIDATION KINETICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; CERULOPLASMIN; COPPER; HUMANS; IRON; MALE; SCHIZOPHRENIA; SPECTROPHOTOMETRY, ATOMIC; STATISTICS; STATISTICS AS TOPIC;

EID: 33747151612     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.05.027     Document Type: Article

References (28)

1. Abood L.G., Gibbs F.A., and Gibbs E. Comparative study of blood ceruloplasmin in schizophrenia and other disorders. AMA Arch. Neurol. Psychiatr. 77 (1957) 643-645
2. Akerfeldt S. Oxidation of N,N-dimethyl-p-phenylenediamine by serum from patients with mental illness. Science 125 (1957) 117-119
3. Alias A.G., Vijayan N., Nair D.S., and Sukumaran M. Serum ceruloplasmin in schizophrenia: significant increase in acute cases especially in catatonia. Biol. Psychiatry 4 (1972) 231-238
4. Baron M., Perlman R., Levitt M., et al. Plasma copper and dopamine-beta-hydroxylase in schizophrenia. Biol. Psychiatry 17 (1982) 115-120
5. Barrass B.C., Coult D.B., Drysdale A.C., and Marjoy D.H. Inhibition and activation of ceruloplasmin by extracts from the urine of schizophrenic patients. Biochem. Pharmacol. 19 (1970) 1675-1679
6. Bartlett W.P., Li X.S., and Connor J.R. Expression of transferrin mRNA in the CNS of normal and jumpy mice. J. Neurochem. 57 1 (1991) 318-322
7. Bloch B., Popovici T., Levin M.J., Tuil D., and Kahn A. Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc. Natl. Acad. Sci. U. S. A. 82 19 (1985) 6706-6710
8. Bock E., Weeke B., and Rafaelsen O.J. Serum proteins in acutely psychotic patients. J. Psychiatr. Res. 9 (1971) 1-9
9. Bowman M.B., and Lewis M. The copper hypothesis of schizophrenia: a review. Neurosci. Biobehav. Rev. 6 (1982) 321-328
10. Chugh T., Dhingra R., Gulati R., and Bathla J. Copper metabolism in schizophrenia. Indian J. Med. Res. 61 (1973) 1147-1152
11. Connor J.R., Roskams A.J., Menzies S.L., and Williams M.E. Transferrin in the central nervous system of the shiverer mouse myelin mutant. J. Neurosci. Res. 36 5 (1993) 501-507
12. de Arriba Zerpa G.A., Saleh M.C., Fernandez P.M., Guillou F., Espinosa de los Monteros A., de Vellis J., Zakin M.M., and Baron B. Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line. J. Neurosci. Res. 61 4 (2000) 388-395
13. Frangos-Plemenos M., Agroyannis B., Koutsicos D., Tzanatos-Exarchou H., Logothetis E., Sarris E., Kaya S., and Yatzidis H. Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis. Int. J. Artif. Organs 10 (1987) 195-198
14. Frohman C.E., Goodman M., Luby E.D., et al. Ceruloplasmin, transferrin, and tryptophan in schizophrenia. AMA Arch. Neurol. Psychiatr. 79 (1958) 730-734
15. Giner J., Morell M., and Osorio C. Serum levels of ceruloplasmin as an index of the clinical evolution in schizophrenic patients. Rev. Esp. Fisiol. 28 (1972) 39-42
16. Heilmeyer L., Keiderling W., and Struve C. Kupfer und Eisen al Korpereigne Wirkstoffe und Ihre Bedeutung Beim Krankheitsgeschehen (1941), Fischer, Jena
17. Herran. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res. 94 (2000) 51-58
18. Lyko J. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions. Acta Med. Pol. 8 (1967) 269-277
19. Martens S., Valbo S., and Melander B. Studies on the role of ceruloplasmin in schizophrenia. Int. Rev. Neurobiol. 1 (1959) 333-342
20. Nechifor M., Vaideanu C., Palamaru I., et al. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J. Am. Coll. Nutr. 23 (2004) 549S-551S
21. Olatunbosun D.A., Akindele M.O., Adadevoh B.K., and Asuni T. Serum copper in schizophrenia in Nigerians. Br. J. Psychiatr. 127 (1975) 119-121
22. Ostfeld A.M., Abood L.G., and Marcus D.A. Studies with ceruloplasmin and a new hallucinogen. AMA Arch. Neurol. Psychiatr. 79 (1958) 317-322
23. Pfeiffer C.C., and Iliev V. A study of zinc deficiency and copper excess in the schizophrenias. Int. Rev. Neurobiol. Suppl. 1 (1972) 141-165
24. Rahman B., Rahman M.A., and Hassan Z. Variation of copper and ceruloplasmin levels with liver function tests in schizophrenic patients. Biomedicine 29 (1978) 238-241
25. Saleh M.C., Espinosa de los Monteros A., de Arriba Zerpa G.A., Fontaine I., Piaud O., Djordjijevic D., Baroukh N., Garcia Otin A.L., Ortiz E., Lewis S., Fiette L., Santambrogio P., Belzung C., Connor J.R., de Vellis J., Pasquini J.M., Zakin M.M., Baron B., and Guillou F. Myelination and motor coordination are increased in transferrin transgenic mice. J. Neurosci. Res. 72 5 (2003) 587-594
26. Topham R.W., and Frieden E. Identification and purification of a non-ceruloplasmin ferroxidase of human serum. J. Biol. Chem. 245 (1970) 6698-6705
27. Voet D., and Voet J.G. Biochemistry (1990), John Wiley and Sons, New York
28. Yanik M., Kocyigit A., and Tutkun H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol. Trace Elem. Res. 98 (2004) 109-117